Reshed Abohalaka

Dr. Reshed Abohalaka

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2023 in Heliyon
Verified
Journal Article
Open access
RAReshed Abohalaka
Reshed Abohalaka
Chronic pulmonary diseases such as asthma, COPD, and Idiopathic pulmonary fibrosis are significant causes of mortality and morbidity worldwide. Currently, there is no radical treatment for many chronic pulmonary diseases, and the treatment options focus on relieving the symptoms and improving lung function. Therefore, efficient therapeutic agents are highly needed. Bronchial epithelial cells and airway smooth muscle cells and their crosstalk play a significant role in the pathogenesis of these diseases. Thus, targeting the interactions of these two cell types could open the door to a new generation of effective therapeutic options. However, the studies on how these two cell types interact and how their crosstalk adds up to respiratory diseases are not well established. With the rise of modern research tools and technology, such as lab-on-a-chip, organoids, co-culture techniques, and advanced immunofluorescence imaging, a substantial degree of evidence about these cell interactions emerged. Hence, this contribution aims to summarize the growing evidence of bronchial epithelial cells and airway smooth muscle cells crosstalk under normal and pathophysiological conditions. The review first discusses the impact of airway smooth muscle cells on the epithelium in inflammatory settings. Later, it examines the role of airway smooth muscle cells in the early development of bronchial epithelial cells and their recovery after injury. Then, it deliberates the effects of both healthy and stressed epithelial cells on airway smooth muscle cells, taking into account three themes; contraction, migration, and proliferation.

10 December 2024 in Clinical and Translational Allergy
Verified
Journal Article
Open access
RAReshed Abohalaka
Reshed Abohalaka
SESelin Ercan
Selin Ercan
LLLauri Lehtimäki
Lauri Lehtimäki
LELinda Ekerljung
Linda Ekerljung
HBHelena Backman
Helena Backman
HKHannu Kankaanranta
Hannu Kankaanranta
Although asthma is more frequently diagnosed in childhood, a substantial proportion of cases manifests in adulthood. Nonetheless, few studies have comprehensively examined asthma incidence across different ages, genders, and asthma phenotypes. We conducted a retrospective evaluation of asthma incidence from birth to late adulthood, stratified by age, gender, and the presence or absence of allergies. Our analysis indicates that a significant number of asthma cases emerged in adulthood, particularly among middle‐aged women, with adult‐onset asthma surpassing childhood‐onset asthma after the age of 35 years. Additionally, allergic asthma was more common in younger than older individuals but decreases with age, ultimately leading to a higher proportion of non‐allergic asthma in older than younger individuals. These findings underscore the predominance of adult‐onset asthma among females and confirm the majority of allergic asthma in children, which declines with age. Additionally, increasing age is associated with increased incidence of non‐allergic asthma. Asthma heterogeneity should be considered in both clinical management and research.

8 March 2025 in Journal of Allergy and Clinical Immunology: Global
Verified
Journal Article
Open access
RAReshed Abohalaka
Reshed Abohalaka
SESelin Ercan
Selin Ercan
LLLauri Lehtimäki
Lauri Lehtimäki
SESaliha Selin Özuygur Ermis
Saliha Selin Özuygur Ermis
DLDaniil Lisik
Daniil Lisik
HKHannu Kankaanranta
Hannu Kankaanranta
The use of blood eosinophil count (BEC) as a prognostic biomarker in the management of conditions such as asthma and chronic obstructive pulmonary disease (COPD) may be complicated by factors such as atopy, age, sex, smoking, and comorbidities. We sought to produce reference values for BEC, considering age, asthma, COPD, and clinical allergy for the general adult population. The West Sweden Asthma Study constitutes a population-representative clinical epidemiological cohort of randomly selected adults in Western Sweden. From this cohort, 1145 individuals took part in clinical examinations, including skin prick testing, specific IgE, and BEC. The upper limit (95th percentile) of BEC varied by age. It ranged from 400 to 500 cells/μL in the full sample and from 300 to 400 cells/μL in subjects without asthma, COPD, and clinical allergy (n = 710). Sex, smoking, atopy, clinical allergy, obesity, asthma, COPD, diabetes, and hypertension were statistically significantly associated with higher BEC levels. However, only asthma and clinical allergy in the full sample, and obesity and diabetes in those without asthma, COPD, or clinical allergy, remained statistically significant with higher BEC levels in multivariable regression analyses. In a population-representative sample, the upper limit of BEC in healthy adults ranged between 300 and 400 cells/μL, varying by age. Age, smoking, obesity, asthma, COPD, and clinical allergy influence BEC levels and should be considered in clinical interpretation.

23 July 2021 in Türkiye Halk Sağlığı Dergisi
Verified
Journal Article
Open access
RAReshed Abohalaka
Reshed Abohalaka
SYSıdıka Tekeli̇ Yeşi̇l
Sıdıka Tekeli̇ Yeşi̇l
Objective: The aim of this study is to determine perceived language barriers in accessing healthcare services according to Syrian refugees and the methods they used to cope with this problem. Methods: The study was a descriptive study. A survey was carried out among Syrian adults visiting two hospitals in Ankara. Results: Of the 221 participants, 11.1% stated that they speak Turkish, 48.5% of them used hospital interpreters while 20.6%, 17.6% and 13.2% of them did not get any help, used ad hoc interpreters and used a private interpreter respectively. Employment status and having social relationships with locals had statistically significant relationships with learning the Turkish language. The language barrier was more common, among participants, who were married, unemployed, illiterate, had no Turkish-speaking relatives or had diseases. Gender, economic status, having Turkish-speaking relatives and having diseases were variables showing association with the method they used to cope with the language barrier. Conclusion: More disadvantaged refugees in terms of socio-economic factors should be prioritized in policies and projects aiming to reduce language barrier in accessing health services. Additionally, supporting refugees regarding employment and social relationships with locals would contribute to eliminate language barrier in accessing healthcare services.

7 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RAReshed Abohalaka
Reshed Abohalaka
SESelin Ercan
Selin Ercan
PIPinja Ilmarinen
Pinja Ilmarinen
HBHelena Backman
Helena Backman
LELinda Ekerljung
Linda Ekerljung
HKHannu Kankaanranta
Hannu Kankaanranta
Obesity has been associated with increased prevalence of asthma in cross-sectional studies. We aim to examine the relation of obesity and weight change to 8-year asthma incidence in a randomly selected population-based adult cohort. West Sweden asthma study survey was performed in 2008 (18,087 participated) and follow-up in 2016 (12,449 participated). Participants responded to a questionnaire on these two occasions. Obesity was defined as body mass index (BMI) ≥ 30 (kg/m2), and overweight as 25 ≤ BMI < 30 (kg/m2). Asthma was defined with affirmative answer to the question “Have you been diagnosed with asthma by a physician?“. Asthma incidence was reported per 1000 person-year over the 8-year follow-up period. Among participants without asthma (N = 10,769) in 2008, asthma incidence was 1.8 per 1000 person-year. Asthma incidence was higher in 40–60 years old, normal, or overweight participants who gained ≥ 4 BMI (kg/m2), or in those who were obese with a stable BMI. Asthma incidence sharply increased in those who gained ≥ 4 BMI (kg/m2), especially in women. Additionally, the risk of asthma was significantly higher in a dose-dependent manner among those who gained ≥ 0.5 BMI (kg/m2) compared to those with stable, normal weight. The risk of asthma was higher in those who were obese at baseline regardless of their weight change than individuals with stable, normal weight. Our findings highlight the necessity for health care to integrate weight management strategies as a key component of asthma prevention and care, particularly for women in middle age who are overweight or obese.

18 September 2025 in Clinical and Translational Allergy
Verified
Journal Article
Open access
RAReshed Abohalaka
Reshed Abohalaka
SESelin Ercan
Selin Ercan
LLLauri Lehtimäki
Lauri Lehtimäki
SESaliha Selin Özuygur Ermis
Saliha Selin Özuygur Ermis
DLDaniil Lisik
Daniil Lisik
HKHannu Kankaanranta
Hannu Kankaanranta
Background: Fractional exhaled nitric oxide (FENO) is used to differentiate asthma inflammatory phenotypes and guide its management. However, data on FENO reference values in a representative adult population is limited. We aim to derive reference values and determinants of FENO in a representative adult population.Methods: The West Sweden Asthma Study is a clinical‐epidemiological population‐representative study of randomly selected adults in Western Sweden. From this cohort, 943 subjects participated in comprehensive clinical investigations, including skin prick testing (SPT), specific immunoglobulin E (sIgE) analysis, and FENO measurement. Clinical allergy was defined as co‐occurrence of atopy (positivity to SPT or sIgE) and self‐reported allergic symptoms to the same allergen family. FENO levels were analysed in relation to the presence or absence of clinical allergy, asthma, and other factors.Results: The 95th percentile of FENO ranged from 34 parts per billion (ppb) in those between 30 and 40 years old to 52 ppb in those ≤ 30 years old in the entire sample (N = 943), and from 26 to 37 ppb in those without clinical allergy, asthma, or chronic obstructive pulmonary disease (COPD) (n = 587), depending on age. Sex, smoking, clinical allergy, atopy, asthma, and hypertension influenced FENO levels, meanwhile, age, asthma, clinical allergy, and reversibility‐related variables were significant determinants of FENO levels.Conclusion: The 95th percentile (upper normal limit) for FENO ranges from 34 to 52 ppb overall, and from 26 to 37 ppb in those without clinical allergy, asthma, or COPD, depending on age. These findings provide a guide for interpreting FENO in the general population.